EGFR mutations based on circulating free DNA (cfDNA) in the subset of Japanese patients (pts) from IPASS (IRESSA Pan ASia Study), a Phase III study of first-line gefitinib (G) vs carboplatin/paclitaxel (C/P) in clinically selected patients with advanced non-small-cell lung cancer (NSCLC)
Other conference paper


Times Cited
Web of Science0WOS source URL (as at 03/08/2020) Click here for the latest count
Altmetrics Information
.

Other information
All Author(s) ListYamamoto N, Ichinose Y, Nishiwaki Y, Ohe Y, Nishio K, Jiang H, Duffield E, Saijo N, Mok T, Fukuoka M
Name of ConferenceAnnual Meeting of the EORTC/NCI/ASCO on Molecular Markers in Cancer
Start Date of Conference15/10/2009
End Date of Conference17/10/2009
Place of ConferenceBrussels
Country/Region of ConferenceBelgium
Journal nameEJC Supplements
Detailed descriptionorganized by EORTIC/NCI/ASCO,
Year2009
Month10
Day1
Volume Number7
Issue Number4
PublisherPERGAMON-ELSEVIER SCIENCE LTD
Pages10 - 10
ISSN1359-6349
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology

Last updated on 2020-04-08 at 03:58